Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

European Journal of Cancer(2022)

引用 30|浏览12
暂无评分
摘要
•Combined CCR5 and PD-1 blockade shows a beneficial toxicity pattern in MMRp CRC.•Though clinical activity was limited, overall survival was longer than expected.•A high efficacy of poststudy salvage treatment was observed.•Translational analyses showed an alteration of the micromilieu.
更多
查看译文
关键词
Chemokine,Micromilieu,PD-1 blockade,Mismatch repair proficient,Colorectal cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要